MOH — authorised 1 September 1977
- Marketing authorisation holder: PROCTER AND GAMBLE
- Status: likely_approved
MOH authorised Didronel on 1 September 1977
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 1 September 1977.
PROCTER AND GAMBLE holds the Israeli marketing authorisation.